Bacteriophages

Function

Although bacteriophages cannot infect and replicate in human cells, they are an important part of the human microbiome and a critical mediator of genetic exchange between pathogenic and nonpathogenic bacteria.[5][6] The transfer of genes from 1 bacterial strain to another by a bacteriophage is called transduction and can occur in a generalized or specific manner.

Generalized Transduction

In generalized transduction, random pieces of bacterial genomic DNA are packaged inside phage capsids instead of phage genomic DNA as the host cell disintegrates from lytic replication. Should the phage carrying this bacterial DNA inject it into a healthy host cell, it may integrate into the chromosome of that bacterium, altering its genome and that of its daughter cells.

Specialized Transduction

In specialized transduction, it is thought that lysogenic phages, amplified in a population of bacteria, excise some bacterial DNA with their genome when initiating a lytic replication cycle. Because the lysogens share the same integration site, all progeny phages transduce the same bacterial gene to their new hosts.

In addition to genetic exchange, bacteriophages can alter microbial populations because they prey on specific species of bacteria while leaving others unharmed. For more than 100 years, research has attempted to use this property to treat pathogenic bacterial infections in people and animals. Although wild phages probably have transient effects on wild bacterial populations,[7] many obstacles exist to the clinical use of lytic bacteriophages as antimicrobial therapy (phage therapy) in humans. Wild bacterial strains are diverse; many resist 1 or multiple phages. Many resistance mechanisms are known, with one famous example being the CRISPR-Cas9 system, which has been engineered as a tool for genetic manipulation in the lab and originated as a bacterial defense mechanism against bacteriophage infection.[8] In addition, phages are much more immunogenic than antimicrobial drugs and are rapidly cleared from the blood by the reticular endothelial system. Their large size relative to antimicrobial drugs likely limits their use to topical applications if effective phage cocktails are found. Some investigators have suggested that phage enzymes, which can penetrate bacterial cell walls, may be a more straightforward strategy.[9] To date, no randomized, controlled, double-blind trials have shown either strategy's efficacy in humans.

Clinical Significance

Phages are clinically significant for several reasons. First, many highly pathogenic bacterial toxins are encoded by bacteriophage genomes, such that the host bacterium is only pathogenic when lysogenized by the toxin-encoding phage. Examples are the cholera toxin in Vibrio cholerae[10], the diphtheria toxin in Corynebacterium diphtheriae,[11] botulinum neurotoxin in Clostridium botulinum,[12] the binary toxin of Clostridium difficile,[13] and Shiga toxin of Shigella species.[10][14][10]. Without their phage-encoded toxins, these bacterial species are either much less pathogenic or not. Why phages encode these toxins is not known. While cholera toxin arguably helps both the phage and its host reach their next victim by inducing copious, watery diarrhea, the paralysis resulting from botulinum toxin would seem to have the opposite effect.

Second, bacteriophages are vectors for horizontal gene transfer, including antimicrobial resistance genes.[5] They also have been engineered to introduce genes into specific strains for clinical effect, although this use is currently in the testing stage.[12]

A third clinically relevant aspect of bacteriophages is that their detection can be used as a biomarker for the presence of their host in a complex environmental sample. This is most commonly used as a surrogate for fecal contamination of water sources. If the phage is present, the host most likely is as well. Alternatively, phages have been engineered to produce a detectable molecule, such as luciferase, when they infect their host to detect bacteria in a mixed environmental sample.[13]

While mostly supplanted by newer technologies, bacteriophages are also clinically relevant for their ability to distinguish strains of the same bacterial species. Most species of bacteria studied have multiple bacteriophage pathogens, just as humans are susceptible to multiple viruses. Different strains within a species are resistant to some phages and not others. By infecting each strain systematically with a standardized panel of phages for that species, each strain can be identified by the susceptibility and resistance pattern of each phage type. For example, phage typing of Staphylococcus aureus utilized a standardized panel of bacteriophages shared internationally to differentiate strains of S. aureus. Before the development of molecular methods, such as multilocus sequence typing and pulsed-field gel electrophoresis, phage typing was the criterion standard for tracking strains for epidemiological purposes.[14]

Finally, bacteriophages were the first type of virus discovered and were involved in many of the fundamental discoveries of molecular biology. For example, the proof that DNA was the molecule that transmitted genetic information, the basic mechanisms of gene regulation, and the genetic code, to name but a few, were all discovered using bacteriophages.

Enhancing Healthcare Team Outcomes

Antibiotic Resistance and Infection Control

Bacteriophages are drivers of bacterial evolution in the human microbiome. Prophage can be induced to switch to the lytic replication cycle by host cell stress, including antimicrobial drugs. Therefore, antibiotic treatments, especially those targeting gut microbial flora, can be expected to alter the viral (phage) microbiome as well. Bacteriophages are not as easily inactivated as vegetative bacterial cells but are vulnerable to UV inactivation, autoclaving, and standard hospital disinfection procedures.

Bacterial Toxin Mediated Disease

It is important for all team members caring for a patient with a phage-borne toxin-mediated disease, such as cholera or shigella, that disinfection procedures be chosen for their ability to inactivate viruses and bacteria. Even though bacteriophages do not infect human cells directly, they can mediate virulence gene transfer from pathogenic to non-pathogenic bacterial strains.